Neuro-Ophthalmology

1-12 of 12

Beyond IGF-1R: IL-6R Inhibition and Future Sequencing
Beyond IGF-1R: IL-6R Inhibition and Future Sequencing
MinuteCE®
Beyond IGF-1R: IL-6R Inhibition and Future Sequencing
Prem S. Subramanian, MD, PhD; Kimberly Cockerham, MD
1.00 program credit
- Prem S. Subramanian, MD, PhD
- Kimberly Cockerham, MD
1.00 program credit
Designing Efficient Clinic Workflows for TED Therapy Access
Designing Efficient Clinic Workflows for TED Therapy Access
MinuteCE®
Designing Efficient Clinic Workflows for TED Therapy Access
Prem S. Subramanian, MD, PhD; Kimberly Cockerham, MD
1.00 program credit
- Prem S. Subramanian, MD, PhD
- Kimberly Cockerham, MD
1.00 program credit
Comparing Trial Designs & Outcomes Across IGF-1R Therapies
Comparing Trial Designs & Outcomes Across IGF-1R Therapies
MinuteCE®
Comparing Trial Designs & Outcomes Across IGF-1R Therapies
Andrea Lora Kossler, MD, FACS; Kimberly Cockerham, MD
1.00 program credit
- Andrea Lora Kossler, MD, FACS
- Kimberly Cockerham, MD
1.00 program credit
Understanding IGF-1R Inhibition: Mechanism & Clinical Implications
Understanding IGF-1R Inhibition: Mechanism & Clinical Implications
MinuteCE®
Understanding IGF-1R Inhibition: Mechanism & Clinical Implications
Prem S. Subramanian, MD, PhD; Andrea Lora Kossler, MD, FACS
1.00 program credit
- Prem S. Subramanian, MD, PhD
- Andrea Lora Kossler, MD, FACS
1.00 program credit
Applying CAS, EUGOGO, VISA: A Micro Case
Applying CAS, EUGOGO, VISA: A Micro Case
MinuteCE®
Applying CAS, EUGOGO, VISA: A Micro Case
Prem S. Subramanian, MD, PhD; Andrea Lora Kossler, MD, FACS
1.00 program credit
- Prem S. Subramanian, MD, PhD
- Andrea Lora Kossler, MD, FACS
1.00 program credit
Why Staging TED Correctly Matters Even When CAS Is Low
Why Staging TED Correctly Matters Even When CAS Is Low
MinuteCE®
Why Staging TED Correctly Matters Even When CAS Is Low
Andrea Lora Kossler, MD, FACS; Kimberly Cockerham, MD
1.00 program credit
- Andrea Lora Kossler, MD, FACS
- Kimberly Cockerham, MD
1.00 program credit
MinuteCE®
Severity Matters: Aligning Thyroid Eye Disease Assessment With Modern Therapeutic Advances
Prem S. Subramanian, MD, PhD; Andrea Lora Kossler, MD, FACS
1.00 credit 8 episodes
- Prem S. Subramanian, MD, PhD
- Andrea Lora Kossler, MD, FACS
- Kimberly Cockerham, MD
1.00 credit 8 episodes
Why QoL Measures Change TED Management
Why QoL Measures Change TED Management
MinuteCE®
Why QoL Measures Change TED Management
Prem S. Subramanian, MD, PhD; Kimberly Cockerham, MD
1.00 program credit
- Prem S. Subramanian, MD, PhD
- Kimberly Cockerham, MD
1.00 program credit
Overcoming Real-World Barriers to TED Treatment 
Overcoming Real-World Barriers to TED Treatment 
MinuteCE®
Overcoming Real-World Barriers to TED Treatment 
Prem S. Subramanian, MD, PhD; Andrea Lora Kossler, MD, FACS
1.00 program credit
- Prem S. Subramanian, MD, PhD
- Andrea Lora Kossler, MD, FACS
1.00 program credit
Emerging Focus in NAION: Sharpening Diagnostic Precision for Tomorrow’s Treatments
Emerging Focus in NAION: Sharpening Diagnostic Precision for Tomorrow’s Treatments
CME/CE Broadcast Replay
Emerging Focus in NAION: Sharpening Diagnostic Precision for Tomorrow’s Treatments
Prem S. Subramanian, MD, PhD; Andrew G. Lee, MD
1.00 credit
- Prem S. Subramanian, MD, PhD
- Andrew G. Lee, MD
- Valerie Biousse, MD
1.00 credit
Diagnosis and Treatment of Neurosarcoidosis
Diagnosis and Treatment of Neurosarcoidosis
Focus on Neurology and Psychiatry
Diagnosis and Treatment of Neurosarcoidosis
Leslie P. Lundt, MD; David R. Spiegel, MD
- Leslie P. Lundt, MD
- David R. Spiegel, MD
Using Eye-Tracking Technology to Evaluate Traumatic Brain Injury
Using Eye-Tracking Technology to Evaluate Traumatic Brain Injury
Clinician's Roundtable
Using Eye-Tracking Technology to Evaluate Traumatic Brain Injury
Mark Nolan Hill, MD; Jam Ghajar, MD, PhD
- Mark Nolan Hill, MD
- Jam Ghajar, MD, PhD

1-12 of 12

Title